Internal medicine

Chemotherapy-induced nausea and vomiting

Nausea

Intensive care medicine

Palonosetron

Chemotherapy

Vomiting

Antiemetic

Anesthesia

Medicine

Cancer Treatment and Research Communications

The significant physical and emotional effects of chemotherapy-induced nausea and vomiting (CINV) are experienced by cancer patients. Severe symptoms decrease the patient's quality of life and potentially deters further treatment. The five main forms of CINV (i.e., acute, delayed, anticipatory, breakthrough, and refractory) require different treatment regimens, which often include 5-HT3 receptor antagonists, NK1 receptor antagonists, and corticosteroids. Despite a significant amount of research and development of antiemetic agents, management of CINV remains a great challenge with many needs waiting to be adequately addressed, such as controlling non-acute CINV, developing appropriate CINV treatment protocols for multiple-day chemotherapy patients, and providing options for those prone to CINV despite treatment. Further research is required to optimize CINV management for these patients.

Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Recommendations, and New Trends